Skip to content
Clinical Trials – home
Therapeutic area

Psychiatric disorders – page 18

  • 548 clinical trials
  • 257 recruiting
  • 147 conditions
  • 26 countries

Conditions in this area

147 conditions with trials, the busiest first

Clinical trials in Psychiatric disorders

548 trials across Europe, recruiting first

Type of trial
Recruitment status
Quick filters

548 clinical trials

Study on AVB-101 for Patients with Frontotemporal Dementia with Progranulin Mutations

InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:AVB-101
  • Sponsor:Aviadobio Limited

Study on Mifepristone for Patients with Treatment-Resistant Post-Traumatic Stress Disorder (PTSD)

Registered drug
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years
  • Substances:Mifepristone
  • Sponsor:Amsterdam UMC Stichting

Study on Reducing Suicidal Thoughts in Emergency Patients Using Nitrous Oxide and Oxygen Therapy

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Nitrogen
  • Sponsor:Centre Hospitalier Regional Universitaire De Tours

Study on Buprenorphine for Treating Severe Suicidal Thoughts in Patients with Major Depression

Registered drug
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Buprenorphine
  • Sponsor:Centre Hospitalier Universitaire De Nimes

Psychotic disorder+1

Recruiting

Study on Improving Social Skills in Schizophrenia Using Oxytocin or Placebo as an Add-On Treatment for Patients with Schizophrenia Spectrum Disorders

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:Oxytocin
  • Sponsor:Zentralinstitut Fuer Seelische Gesundheit

Study on Pramipexole for Patients with Resistant Obsessive-Compulsive Disorder (OCD)

Registered drugNo placebo
Countries:PortugalPortugal
  • Participants:18–64 years
  • Substances:Pramipexole Dihydrochloride Monohydrate
  • Sponsor:CCAB Centro Clinico Academico Braga Associacao

Study on the Effects of Intranasal Oxytocin on Learning in Youth with Autism Spectrum Disorder

Registered drug
Countries:NorwayNorway
  • Participants:0–17 years · 18–64 years
  • Substances:Oxytocin
  • Sponsor:Oslo University Hospital HF

Long-Term Safety Study of ACP-204 for Adults with Alzheimer's Disease Psychosis

InvestigationalNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:ACP-204 tartrate
  • Sponsor:Acadia Pharmaceuticals Inc.

Agitation

Recruiting

Study on Dexmedetomidine, Midazolam, and Lorazepam for Treating Acute Agitation in Emergency Psychiatry Patients

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years
  • Substances:Dexmedetomidine
  • Sponsor:Rigshospitalet

Study on Efavirenz for Patients with Early Alzheimer's Disease

Investigational
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Efavirenz
  • Sponsor:Amsterdam UMC Stichting

Study on the Effects of Donepezil in Patients with Anorexia Nervosa

Registered drug
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Donepezil Hydrochloride
  • Sponsor:Groupe Hospitalier Universitaire Paris Psychiatrie Et Neuroscience

Paedophilia

Recruiting

Study on Fluoxetine and E-therapy for Men Seeking Help with Pedophilic Disorder

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years
  • Substances:Fluoxetine
  • Sponsor:Karolinska University Hospital

Substances studied in this area

The therapies tested most often in Psychiatric disorders trials.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.